Purpose: To report long-term follow-up of a case of paraneoplastic optic neuropathy (PON) successfully treated with combination therapy. Observations: We present a confirmed case of PON from cutaneous melanoma with nearly six years of meticulous follow-up in which vision was preserved and disease remission was successfully induced with combination mycophenolate mofetil, prednisone, and plasmapheresis therapy. Conclusions and importance: Treatment of PON and long-term follow-up are not well described in the literature. In our case of PON, vision was preserved and disease remission was achieved with mycophenolate mofetil, prednisone, and plasmapheresis. Such information may be useful for future cases of PON
Purpose To analyze the functional outcome with regard to the development of visual acuity and rad...
Aquaporin-4 antibody (AQP4-IgG) neuromyelitis optica spectrum disorders (NMOSD) are rare idiopathic ...
textabstractA 68 year old woman developed oculomotor paresis shortly after metastatic progress...
Importance: Melanoma associated retinopathy (MAR) is a paraneoplastic syndrome in which anti-retinal...
Introduction: We describe bilateral optic neuropathy in a patient affected by ovarian carcinoma trea...
A 68-year-old woman presented with bilateral visual loss as the only clinical manifestation of an oc...
Lesions involving the visual system due to the remote effect of cancer are uncommon. Their clinical ...
Paraneoplastic syndromes (PNS) involving the central nervous system are a rare manifestation of mali...
Purpose: To report on two cases with paraneoplastic acute exudative polymorphous vitelliform maculop...
International audiencePurpose: Melanoma-associated retinopathy (MAR) is a rare paraneoplastic syndro...
Optic neuropathies that develop during the course of cancer treatment may be due to compression, inf...
This 46-year-old woman noted progressive bilateral visual loss over a 10-month period. She had a mal...
Sudden bilateral loss of vision; RAPD OSA 68-year old female with a sudden loss of vision OU. Previo...
We have reported an autopsy case of neuromyelitis optica (NMO) that exhibited persisting active infl...
Paraneoplastic optic neuropathy results in a subacute, progressive, bilateral loss of vision, usuall...
Purpose To analyze the functional outcome with regard to the development of visual acuity and rad...
Aquaporin-4 antibody (AQP4-IgG) neuromyelitis optica spectrum disorders (NMOSD) are rare idiopathic ...
textabstractA 68 year old woman developed oculomotor paresis shortly after metastatic progress...
Importance: Melanoma associated retinopathy (MAR) is a paraneoplastic syndrome in which anti-retinal...
Introduction: We describe bilateral optic neuropathy in a patient affected by ovarian carcinoma trea...
A 68-year-old woman presented with bilateral visual loss as the only clinical manifestation of an oc...
Lesions involving the visual system due to the remote effect of cancer are uncommon. Their clinical ...
Paraneoplastic syndromes (PNS) involving the central nervous system are a rare manifestation of mali...
Purpose: To report on two cases with paraneoplastic acute exudative polymorphous vitelliform maculop...
International audiencePurpose: Melanoma-associated retinopathy (MAR) is a rare paraneoplastic syndro...
Optic neuropathies that develop during the course of cancer treatment may be due to compression, inf...
This 46-year-old woman noted progressive bilateral visual loss over a 10-month period. She had a mal...
Sudden bilateral loss of vision; RAPD OSA 68-year old female with a sudden loss of vision OU. Previo...
We have reported an autopsy case of neuromyelitis optica (NMO) that exhibited persisting active infl...
Paraneoplastic optic neuropathy results in a subacute, progressive, bilateral loss of vision, usuall...
Purpose To analyze the functional outcome with regard to the development of visual acuity and rad...
Aquaporin-4 antibody (AQP4-IgG) neuromyelitis optica spectrum disorders (NMOSD) are rare idiopathic ...
textabstractA 68 year old woman developed oculomotor paresis shortly after metastatic progress...